A bundle of opioid-sparing strategies to eliminate routine opioid prescribing in a urogynecology practice.

Background: Current evidence supports that many patients do not use prescribed opioids following reconstructive pelvic surgery, yet it remains unclear if it is feasible to eliminate routine opioid prescriptions without a negative impact on patients or providers.

Objective: To determine if there is a difference in the proportion of patients discharged without opioids after implementing a bundle of opioid-sparing strategies and tiered prescribing protocol compared to usual care after minimally invasive pelvic reconstructive surgery (transvaginal, laparoscopic, or robotic). Secondary objectives include measures of patient-perceived pain control and provider workload.

The Impact of an Overactive Bladder Care Pathway on Longitudinal Patient Management.

Importance: Implementation of an overactive bladder (OAB) care pathway may affect treatment patterns and progression.

Objectives: This study aimed to assess the effect of OAB care pathway implementation on treatment patterns for women with OAB.

Study Design: This retrospective cohort study evaluated women with OAB, before (January 1, 2015-December 31, 2017) and after (January 1, 2019-December 31, 2021) care pathway initiation.

The effect of concomitant hysterectomy on complications following pelvic organ prolapse surgery.

Purpose: Pelvic organ prolapse (POP) surgery is performed with and without concomitant hysterectomy depending on a variety of factors. The objective was to compare 30-day major complications following POP surgery with and without concomitant hysterectomy.

Methods: This was a retrospective cohort study using the National Surgical Quality Improvement Program (NSQIP) multicenter database to compare 30-day complications using Current Procedural Terminology (CPT) codes for POP with or without concomitant hysterectomy.